Cantitate/Preț
Produs

Frontiers of Cancer Biology: Current Trends in Cancer Research

Editat de Devavarapu Kasi Viswa Prasad, Sitara Roy
en Limba Engleză Paperback – aug 2025
Frontiers of Cancer Biology: Current Trends in Cancer Research presents the latest research in cancer, which is advancing day by day. This book provides an introduction to cancer genetics, as well as the roles of genomic instability, oncogenes, proto-oncogenes, tumor suppressor genes, and DNA damage and repair in relation to cancer. It then goes on to discuss viral genomics and cancer, epigenetics and cancer, cancer genetics, gene therapy in precision medicine. Finally, this book reviews the future direction of cancer genetics. Frontiers of Cancer Biology: Current Trends in Cancer Research is a valuable resource for researchers and professionals working in cancer biology, as well as academics that want to keep up to date with the field.

  • Provides a comprehensive overview of cancers
  • Explores clinical relevance of cancer in relation to genetics
  • Reviews emerging trends and therapeutic targets in cancer, as well as the future of cancer genetics
Citește tot Restrânge

Preț: 95026 lei

Preț vechi: 123411 lei
-23% Nou

Puncte Express: 1425

Preț estimativ în valută:
18196 18770$ 15080£

Carte nepublicată încă

Doresc să fiu notificat când acest titlu va fi disponibil:

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780443333026
ISBN-10: 0443333025
Pagini: 230
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE

Cuprins

1. Introduction to Cancer Genetics
2. Role of Genomic Instability and Gene Mutations in Carcinogenesis and Metastasis
3. Role of Oncogenes, Proto-oncogenes, and Tumor Suppressor Genes in Cancer Progression
4. The Role of DNA Damage and Repair in Cancer Pathogenesis
5. Viral genomics and cancer
6. Epigenetics and Cancer
7. Cancer Genetics, Chemotherapy and advance therapy
8. Childhood cancer genomics
9. Role of gene therapy and immunotherapy in precision medicine
10. Genetic testing, genetic counseling, and cancer risk assessment during cancer therapy
11. Future directions and progress in cancer genetics